Skip to main content
. 2011 Jul 20;6(7):e22526. doi: 10.1371/journal.pone.0022526

Figure 3. Met-RANTES treatment at different doses modulate pro- and anti- inflammatory cytokine levels in experimental periodontal disease.

Figure 3

C57Bl/6 mice were infected orally with AA, treated with met-RANTES at 0.5 and 5 mg doses or (V) veicule, (-) non treated and (C) control non-infected mice, sacrificed at day 30 post-infection and evaluated for levels of A) IL-1β; B) TNF-α; C) IL-6 and D) IL-10 cytokines. Different italic low case letters represent statistically significant differences among the doses in the same experimental group (P<0.05; One-way ANOVA).